載入...
A mutation-independent CRISPR-Cas9–mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency
Ornithine transcarbamylase (OTC) deficiency is an X-linked urea cycle disorder associated with high mortality. Although a promising treatment for late-onset OTC deficiency, adeno-associated virus (AAV) neonatal gene therapy would only provide short-term therapeutic effects as the non-integrated geno...
Na minha lista:
| 發表在: | Sci Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Association for the Advancement of Science
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015695/ https://ncbi.nlm.nih.gov/pubmed/32095520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aax5701 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|